Intracellular Signalling Pathways and Mood Disorders Cited by

Fol. Biol. 2010, 56, 135-148

https://doi.org/10.14712/fb2010056040135

Intracellular Signalling Pathways and Mood Disorders

Zdeněk Fišar, J. Hroudová

Charles University in Prague, First Faculty of Medicine and General University Hospital in Prague, Department of Psychiatry, Prague, Czech Republic

Received June 2009
Accepted October 2009

Crossref Cited-by Linking

Fi\u0161ar Zden\u011bk, Hroudová J., Singh N., Kop\u0159ivová A., Mace\u010dková D.: Effect of Simvastatin, Coenzyme Q10, Resveratrol, Acetylcysteine and Acetylcarnitine on Mitochondrial Respiration. Fol. Biol. 2016, 62, 53. <https://doi.org/10.14712/fb2016062020053>
Uemura Takuji, Green Marty, Warsh Jerry J.: CACNA1C SNP rs1006737 associates with bipolar I disorder independent of the Bcl-2 SNP rs956572 variant and its associated effect on intracellular calcium homeostasis. The World Journal of Biological Psychiatry 2016, 17, 525. <https://doi.org/10.3109/15622975.2015.1019360>
Rieger Débora K., Cunha Rodrigo M. S., Lopes Mark William, Costa Ana Paula, Budni Josiani, Rodrigues Ana Lúcia S., Walz Roger, Teixeira Edson H., Nascimento Kyria S., Cavada Benildo S., Leal Rodrigo B.: ConBr, a lectin from Canavalia brasiliensis seeds, modulates signaling pathways and increases BDNF expression probably via a glycosylated target. J of Molecular Recognition 2014, 27, 746. <https://doi.org/10.1002/jmr.2401>
Freitas Andiara E., Bettio Luis E.B., Neis Vivian B., Moretti Morgana, Ribeiro Camille M., Lopes Mark W., Leal Rodrigo B., Rodrigues Ana Lúcia S.: Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice. Journal of Psychiatric Research 2014, 58, 137. <https://doi.org/10.1016/j.jpsychires.2014.07.024>
Qin Juan-Juan, Chen Hong-Xia, Zhao Nan, Yuan Li, Zhang You-Zhi, Yang Ri-Fang, Zhang Li-Ming, Li Yun-Feng: The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor. Neuroscience Letters 2014, 582, 104. <https://doi.org/10.1016/j.neulet.2014.09.009>
Fraga Daiane B., Réus Gislaine Z., Abelaira Helena M., De Luca Renata D., Canever Leila, Pfaffenseller Bianca, Colpo Gabriela D., Kapczinski Flávio, Quevedo João, Zugno Alexandra I.: Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration. Rev. Bras. Psiquiatr. 2013, 35, 262. <https://doi.org/10.1590/1516-4446-2012-0858>
Breuer Megan E., Willems Peter H. G. M., Russel Frans G. M., Koopman Werner J. H., Smeitink Jan A. M.: Modeling mitochondrial dysfunctions in the brain: from mice to men. J of Inher Metab Disea 2012, 35, 193. <https://doi.org/10.1007/s10545-011-9375-8>
Maes Michael, Fi\u0161ar Zden\u0115k, Medina Miguel, Scapagnini Giovanni, Nowak Gabriel, Berk Michael: New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates\u2014Nrf2 activators and GSK-3 inhibitors. Inflammopharmacol 2012, 20, 127. <https://doi.org/10.1007/s10787-011-0111-7>
Zhang Yulin, Shi Ying, Qiao Luxin, Sun Yu, Ding Wei, Zhang Honghai, Li Ning, Chen Dexi: Sigma-1 receptor agonists provide neuroprotection against gp120 via a change in bcl-2 expression in mouse neuronal cultures. Brain Research 2012, 1431, 13. <https://doi.org/10.1016/j.brainres.2011.10.053>
Wu YeeWen Candace, Hill Rachel A., Klug Maren, van den Buuse Maarten: Sex-specific and region-specific changes in BDNF\u2013TrkB signalling in the hippocampus of 5-HT1A receptor and BDNF single and double mutant mice. Brain Research 2012, 1452, 10. <https://doi.org/10.1016/j.brainres.2012.03.011>
Fi\u0161ar Zden\u011bk: Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 38, 68. <https://doi.org/10.1016/j.pnpbp.2011.12.010>